Products
CE Global Private Equity offers a wide range of investment products and services for retail and corporate investors.
Investment Performance Case Study
Oxford Nanopore Technologies
Welcome to the Investment Performance Case Study of Oxford Nanopore Technologies , which follows our clients' journeys of investing in Oxford Nanopore Technologies between 30th Sep, 2021 and 31st Dec, 2021, during which the recorded share price produced a gain of 64%.
LSE:ONT
Introduction
Oxford Nanopore Technologies, founded in 2005, develops and sells nanopore-based DNA and RNA sequencing products. Their technology allows for real-time, portable, and scalable sequencing, enabling the analysis of biological data in various settings.
The Oxford Nanopore Technologies Investment Case
Oxford Nanopore Technologies develops molecular sensing technology, including a sequencing platform capable of analysing DNA and RNA. The company emerged from Oxford University and developed its technology for applications spanning scientific research, healthcare and biological analysis.
The Transaction
Oxford Nanopore entered the London Stock Exchange on 30 September 2021 through an initial public offering priced at 425 pence, equivalent to £4.25 per share.
Investment Outcome
Using the provisional study period currently recorded, the shares reached an outcome value of approximately £6.98 by 31 December 2021. This represents an increase of approximately 64.2% against the £4.25 IPO price and reflects the strong market interest surrounding the company following its listing.
- Event: Initial Public Offering
- Exchange: London Stock Exchange
- Study Period: 30 September 2021 – 31 December 2021
- Entry Price: £4.25
- Outcome Price: approximately £6.98
Case Overview
| Company Name : | Oxford Nanopore Technologies |
|---|---|
| Sector : | Technology |
| Event Type : | IPO |
| Buy Advice : | 2021-09-30 |
| Sell Advice : | 2021-12-31 |
| Buy Price : | 4.25 (GBP) |
| Sell Price : | 6.98 (GBP) |
| Profit(%) : | 64% |
Case Studies
